Ze-gen, Inc.

Ze-gen, Inc. Hosts Ribbon Cutting at Demonstration Facility in New Bedford

Ze-gen, Inc. Hosts Ribbon Cutting at Demonstration Facility in New Bedford

July 24, 2007

Facility will pilot company’s innovative waste gasification and renewable energy generation technology

LS9

Robert Walsh Appointed President of LS9, Inc., the Renewable Petroleum Company™

Robert Walsh Appointed President of LS9, Inc., the Renewable Petroleum Company™

July 30, 2007

Oil industry veteran to direct commercial development of DesignerBiofuels™ Products

SAN CARLOS, CA – July 30, 2007 – LS9, Inc., the Renewable Petroleum Company™, has named Robert Walsh its new President, effective immediately. Walsh will lead the rapid commercialization of LS9 DesignerBiofuels™ products, including a pilot facility leading to commercial production.

LS9

LS9 Wins Presidential Green Chemistry Challenge Award

LS9 Wins Presidential Green Chemistry Challenge Award

June 21, 2010

Renewable Petroleum™ technology efficiently converts renewable raw materials into low-carbon fuels and chemicals

SOUTH SAN FRANCISCO, CA -- June 21, 2010 -- LS9, Inc., the Renewable Petroleum Company™, today announced that it has won the U.S. Environmental Protection Agency’s (EPA) highest environmental honor for its revolutionary Renewable Petroleum™ technology that converts sustainable, plant-based materials into low-carbon fuels and chemicals.

Everyday Solutions, Inc.

Fontinalis Partners Announces Investment in Everyday Solutions the Leading Provider of GPS-Driven School Transportation Information Management Systems

Fontinalis Partners Announces Investment in Everyday Solutions the Leading Provider of GPS-Driven School Transportation Information Management Systems

June 18, 2010

Acton, MA / Detroit, MI USA, Jun. 18, 2010 — Fontinalis Partners, LLC, a Michigan-based strategic investment firm, today announced that it has invested in Everyday Solutions, Inc., the leading provider of GPS-driven school transportation information management systems. Existing investors Ascent Venture Partners and Flagship Ventures also participated. The financial terms of the transaction were not disclosed.

LS9, Creator of Synthetic Microbes to Make Biofuel, Edges Toward Moment of Truth

LS9, Creator of Synthetic Microbes to Make Biofuel, Edges Toward Moment of Truth

June 15, 2010

Every hot startup has to put up or shut up at some point. This is when it’s time to stop talking about the gee-whiz founding idea and scientific progress. It’s the point when a company needs to prove it can operate a disciplined, sustainable business. The moment is fast approaching for LS9.

Ensemble Therapeutics Corporation

Ensemble Discovery and Roche Initiate Research Collaboration to Apply New Diagnostic Technology to Optimize Cancer Therapy

Ensemble Discovery and Roche Initiate Research Collaboration to Apply New Diagnostic Technology to Optimize Cancer Therapy

July 30, 2007

Collaboration will enable analysis of critical drug target family in patient cancer biopsies and selection of appropriate therapy

Selventa

Genstruct Appoints David de Graaf as Chief Scientific Officer

Genstruct Appoints David de Graaf as Chief Scientific Officer

June 1, 2010

Renowned Systems Biology Expert to Lead Company’s Scientific Initiatives

CAMBRIDGE, Mass., June 1, 2010 – Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies, today announced that it has appointed industry expert, David de Graaf, Ph.D., as its chief scientific officer (CSO).

Joule Unlimited, Inc.

Joule Elects Ruben Vardanian to Board of Directors

Joule Elects Ruben Vardanian to Board of Directors

June 3, 2010

Cambridge, Mass. – June 3, 2010 – Joule Unlimited, Inc. today announced the election of Ruben Vardanian to its board of directors, gaining the strategic insight of a highly-accomplished, international business leader.

Selventa

Genstruct Appoints David de Graaf as Chief Scientific Officer

Genstruct Appoints David de Graaf as Chief Scientific Officer

June 1, 2010

Renowned Systems Biology Expert to Lead Company’s Scientific Initiatives

CAMBRIDGE, Mass., June 1, 2010 – Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics, molecular diagnostics and patient-specific therapies, today announced that it has appointed industry expert, David de Graaf, Ph.D., as its chief scientific officer (CSO).

Mascoma Corporation

Mascoma Corporation Adds Jim Schumacher as Vice President, Business Development

Mascoma Corporation Adds Jim Schumacher as Vice President, Business Development

August 2, 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mascoma Corporation, a leader in low-carbon cellulosic biomass-to-ethanol production through advanced biotechnology, today announced that Jim Schumacher has joined the company as Vice President, Business Development. In this role, Mr. Schumacher will lead business development activities and negotiations for domestic and foreign opportunities. He will also oversee key strategic partnerships and merger and acquisition activities for the firm.